Prices delayed by at least 15 minutes | Print
4Basebio PLC (4BB)
ORD EUR1.00Open
1,125.00p
Previous close
1,125.00p
Trade high
1,150.00p
Volume
109
Year high
1,820.00p
Year low
1,020.00p
Dividend yield
–
Market capitalisation
£174.06 mn
P/E ratio
–
ISIN
GB00BMCLYF79
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 28/04/2025 | 01:41:16 | 1122.4 | 1 | 11.22 |
| 28/04/2025 | 12:56:06 | 1150 | 0 | 0.00 |
| 28/04/2025 | 09:38:18 | 1122.4 | 100 | 1,122.40 |
| 28/04/2025 | 08:30:19 | 1122.4 | 8 | 89.79 |
| 25/04/2025 | 04:05:11 | 1122.5 | 667 | 7,487.08 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.